Ferrari, Filipe http://orcid.org/0000-0001-6929-8392
Scheffel, Rafael S. http://orcid.org/0000-0002-8858-309X
Martins, Vítor M. http://orcid.org/0000-0002-1483-4335
Santos, Raul D. http://orcid.org/0000-0002-9860-6582
Stein, Ricardo http://orcid.org/0000-0003-2357-5176
Article History
Accepted: 23 November 2021
First Online: 27 December 2021
Declarations
:
: This study was partially supported by the Hospital de Clínicas de Porto Alegre Research Incentive Fund (FIPE-HCPA), Porto Alegre, Brazil, and by the Coordination for the Improvement of Higher Education Personnel—Brazil (CAPES)—funding code 001. FF receives financial support from CAPES. RDS is recipient of a Brazilian National Council for Scientific and Technological Development (CNPq) research scholarship (filing #303734/2018-3). RS receives research productivity funding from CNPq.
: RDS has received honoraria related to consulting, research, and/or speaker activities from Abbott, Amgen, Aché, Amryt, AstraZeneca, Esperion, EMS, Kowa, Hypera, Merck, MSD, Novo Nordisk, Novartis, PTC, Pfizer, Roche, and Sanofi. Filipe Ferrari, Rafael S. Scheffel, Vítor M. Martins, and Ricardo Stein have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: All authors have read and approved the submission.
: Not applicable.
: Not applicable.
: Conception and design of the research; acquisition, analysis, and interpretation of the data; and writing of the manuscript: FF, RSS, VMM, RDS, RS. Critical revision of the manuscript for intellectual content: FF, RSS, RDS, RS.